Market Closed

LGND
Ligand Pharmaceuticals Incorporated
$ 308.79
-2.37%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Ligand Pharmaceuticals Incorporated News

Latest Ligand Pharmaceuticals Incorporated Stock News & LGND Headlines

Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells $1,566,100.00 in Stock
8 days ago | defenseworld.net
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells $1,566,100.00 in Stock
8 days ago | defenseworld.net
Ligand Pharmaceuticals Incorporated (LGND) Q3 2026 Earnings Call Transcript
16 days ago | seekingalpha.com
What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings Call
16 days ago | marketbeat.com
Ligand Reports Third Quarter 2026 Financial Results
17 days ago | globenewswire.com
Ligand to Participate in November Investor Conferences
18 days ago | globenewswire.com
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
a month ago | globenewswire.com
Ligand Acquires Royalty and Milestone Interest in Santen's Ryjunea® from Sydnexis for $23 Million
2 months ago | globenewswire.com
Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech
2 months ago | seekingalpha.com
Ligand to Participate in September Investor Conferences
3 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

LGND
Ligand Pharmaceuticals Incorporated
$ 308.79
-2.37%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago